ARROW ELECTRONICS, INC. (ARW): what the price requires

At today's price, ARROW ELECTRONICS, INC. (ARW) is priced for +3.6% growth. boothcheck doesn't publish a fair value or a price target; it shows what the price assumes, so you can judge whether that bar is too high.

Generated: 2026-07-19 · Source: https://boothcheck.com/report/ARW

Headline

FieldValue
TickerARW
CompanyARROW ELECTRONICS, INC.
Current price$202.39/sh
CompositionGlobal components 70% / Global ECS 30%

What The Price Requires (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

FieldValue
Inversion basiswhole-company
Operating margin needed1.7%
Operating margin today2.8%
Margin compression implied-1.1pp
Implied growth3.6%
Multiple paid14x operating income

The operating-margin requirement is derived from the framework's value band at year 12, a separately labeled basis from the headline growth/duration solve.

Solve inputs: computed at a 8.8% cost of capital with 4% terminal growth over a 5-year stage; each 1pp of cost of capital moves the implied operating-profit growth ~6pp.

How unusual the bet is: within-range

ReferenceValue
vs own history-0.32σ
cohort percentile (of 225 peers)19
implied end-window share0%

Valuation X-Ray

The price is supported by asset-based and relative-multiple and growth-DCF value. A value/asset-supported name, not a pure growth bet.

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

FamilyMedian price/FVModelsReads
Asset1.24x5expensive
Earnings1.34x5expensive
Relative0.41x5justifies
Growth0.61x3justifies

Families that justify the price: Asset, Relative, Growth

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 8.2%); the inversion above states its own rate.

Per-Model Detail (n=18)

ModelFamilyFVPrice/FVApplicableMethodology
DCF Perpetual GrowthGrowth$326.040.62xyesFCF base $0.3B, growth 21% (input: historical growth), terminal g 4.0%, WACC 8.2%, 7yr projection
DCF Exit MultipleGrowth$379.710.53xyesExit EV/EBITDA: 8.9x / 10.9x / 12.9x (bear / base = today's held flat / bull), 7yr
Relative ValuationRelative$265.650.76xyesP/E 18x (static sector reference · 2026-04), scenarios: 14.6x / 18.0x / 21.4x (bear / base = reference held flat / bull), EV/EBITDA 12x
Simple DDMGrowthno
Two-Stage DDMGrowthno
Simple Excess ReturnAsset$151.931.33xyesBV/sh $130.38, ROE (TTM) 10.8%, ke 9.3%
Two-Stage Excess ReturnAsset$163.541.24xyes5yr excess ROE then converge to ke=9.3%
Discounted Future Market CapGrowth$330.650.61xyesRev $33.5B, growth 21% (input: historical growth; tapered), Terminal P/S: 0.3x / 0.3x / 0.4x (bear / base = today's held flat / bull, cap 12x)
Peter Lynch Fair ValueRelative$488.950.41xyesEPS $13.97, growth 35% (input: historical EPS growth), PEG=0.41 (Undervalued)
Margin TrajectoryGrowthno
Earnings Power ValueEarnings$309.930.65xyesNormalized EBIT (5y avg op income, one-time charges added back) $1.43B × (1−23%) / WACC 8.2% → EPV (no growth)
Residual IncomeAsset$165.751.22xyesBV $130.38 + 5yr PV of (ROE (TTM) 10.8% − Kₑ 9.3%) × BV; BV grows 7.0%/yr
Graham NumberAsset$202.441.00xyes√(22.5 × EPS $13.97 × BVPS $130.38) — Graham's conservative floor
EV/EBITDA RelativeRelative$227.820.89xyesEBITDA $1.16B × sector EV/EBITDA 12.0x
FCF YieldEarnings$21.369.48xyesFCF $303.7M / Kₑ 9.3% — zero-growth perpetuity
SBC-Adj FCF YieldEarnings$13.3215.19xyesSBC-adj FCF $0.27B (FCF $0.30B − SBC $0.04B) capitalized at Kₑ
Ben Graham FormulaEarnings$450.770.45xyesEPS $13.97 × (8.5 + 2×15.0%) × (4.4 / 5.3%)
ROIC-Justified P/BAsset$49.404.10xyesBV $130.38 × (ROIC 3.1% / WACC 8.2%)
P/Sales SectorRelative$1620.310.12xyesRevenue $33.51B × sector P/S 2.5x
PEG Fair ValueRelative$523.880.39xyesEPS $13.97 × (PEG 1.5 × growth 25.0% (input: historical EPS growth)) → PE 37.5x
Earnings YieldEarnings$151.031.34xyesEPS $13.97 / required return 9.3% (Rf 4.3% + ERP 5.0%)
Funds From Operations MultipleRelativeno
Clinical Phase NPVGrowthno
MertonAssetno
V5 Mechanicalno

Solvency

FieldValue
Net debt$2.2b
Net debt / NOPAT (after-tax)3.19x
Net debt / operating income (pre-tax)2.45x
Share count CAGR (buyback)-6.9%
Burning cashno

Interest expense is not separately reported in the latest filings, so interest coverage cannot be computed.

Bullet Takeaways

Bull Case

The right way to read Arrow is as a deeply cyclical business at a turning point, because that frame changes what the thin margins mean. A 3% operating margin looks unimpressive until you know it is measured across a cycle that includes a recent components downturn, when customers worked down inventory rather than ordering. The numbers should be read off the trajectory, not the level. In Q1 2026 consolidated sales jumped 39% year over year to $9.5 billion, the Global Components segment grew $758 million sequentially to $6.6 billion, and the company's filing notes it "anticipates that demand for components will continue to gradually increase". A cyclical distributor coming off a trough, with both major segments reaccelerating, is exactly the setup where depressed trailing margins understate normalized earnings power.

The operating leverage in the model is what makes the upswing valuable. Because so much of a distributor's cost base is fixed, incremental revenue drops to profit at a higher rate on the way up. Non-GAAP operating margin expanded 160 basis points year over year in the quarter, and the components segment's margins rose 180 basis points sequentially. That is the mechanical benefit of volume returning to a network that was running below capacity. The recovery is broad, spanning geographies, verticals, and customer types rather than resting on one end market.

The capital allocation seals the bull case. Arrow has been retiring its own stock steadily, shrinking the share count about 7% a year, and in May 2026 the board authorized a fresh $1 billion repurchase program. Buying back shares of a cyclical business when earnings are depressed and the stock trades below where peers and most valuation methods land is high-return capital allocation: each repurchased share retires more earnings power than it would at a mid-cycle multiple. At roughly 16 to 17 times trailing earnings, below the sector median, a recovering distributor compounding fewer shares into a rising earnings base is the straightforward bull thesis.

Bear Case

The variable with the most leverage over Arrow's thesis is the one it cannot control: the macro demand cycle for electronics. This is a business whose revenue is a direct function of how much its customers are building, and that swings with industrial production, semiconductor demand, and the inventory psychology of thousands of manufacturers. The 39% revenue jump in the latest quarter is the upside of that cyclicality, but cyclicality cuts both ways. The recovery is being measured against a depressed prior-year base, and a distributor's earnings can reverse just as fast when customers shift back to working down inventory rather than ordering ahead.

Trade policy sits directly on top of that exposure. Arrow moves components across borders at enormous scale, with a large share of its business in Asia, so tariffs, export controls, and shifting trade rules feed straight into both its costs and its customers' willingness to build. The company itself flags that a higher mix of Asian business carries lower margins, which is why it guided to a seasonal margin headwind in the second quarter. A structural shift in trade policy that reroutes supply chains or raises the cost of moving electronics is a risk the current price, recovering off a trough, does not obviously reflect.

The deeper structural concern is what the low return on capital says about the business model. Arrow earns a return on invested capital of only about 3%, well below its cost of capital, which is the signature of a thin-spread intermediary that adds logistics and credit value but captures little of the economics of the products it moves. Distribution is a scale-and-efficiency game with limited pricing power; the value sits with the chipmakers upstream and the customers downstream. The price embeds operating-profit growth of roughly 9% a year for five years, which is achievable in a recovery but demanding to sustain through the next downturn. If the components upcycle stalls or trade frictions bite, the buyer is left holding a low-return, low-margin business at a multiple that assumed the good part of the cycle would persist.

Valuation

What the price is betting is modest and cycle-aware. At about $233 (June 27, 2026) a share, Arrow trades near 16 times company-wide operating income, which inverts to roughly 9% annual operating-profit growth sustained for about five years. Keep that approximate; it is one solve under fixed assumptions. The inversion notes that the rate is within what Arrow has recently delivered, so the stretch is in duration, not in whether a recovering distributor can grow at that pace for a year. For a business at a cyclical inflection, a mid-single-digit to high-single-digit growth assumption is a reasonable, not aggressive, bar.

The methods land mostly above the price, the pattern of a value-supported cyclical. The relative-multiple family, using a sector price-to-earnings near 18 times and an EV-to-EBITDA comparison, lands in the $227 to $265 range, above the current price. The earnings-power family, capitalizing normalized operating income, lands near $305. The asset-value family is lower, in the $150s, anchored on a high book value of about $130 a share and a mid-teens return on equity. Read together, the methods say the stock trades at or below where peer multiples and normalized earnings power place it, with the asset floor providing support. The one caution is the very low return on invested capital, which is why the asset-based methods sit below the price rather than above it.

Solvency is comfortable. Net debt sits near two times operating income, a manageable level for a business with the working-capital swings of distribution, where inventory and receivables expand in an upturn. The decisive question the valuation poses is one of cycle timing rather than balance-sheet risk: at 16 times trailing earnings that are recovering off a trough, the buyer is paying a below-sector multiple for a business whose normalized earnings are likely higher than the trailing figure, provided the components upcycle holds. The asset-based methods near $150 are the reminder of where value sits if the recovery proves short-lived.

Catalysts

The first quarter of 2026 confirmed the cyclical recovery. Consolidated sales rose 39% year over year to $9.5 billion, with Global Components at $6.6 billion, up $758 million sequentially, and Global ECS at $2.8 billion, up 39%. Non-GAAP operating margin reached 4.2%, expanding 160 basis points year over year, and non-GAAP diluted earnings per share were $5.22, up sharply from the prior-year quarter; these are company-defined measures, and the GAAP earnings base is the relevant one for trailing comparisons.

The forward catalysts are the continued components upturn and capital returns. Management guided second-quarter Global Components sales of $6.80 billion to $7.20 billion, implying 29% to 36% growth year over year, while flagging a seasonal margin headwind from a higher mix of lower-margin Asian business. The board also authorized a new $1 billion share repurchase program effective May 12, 2026. The metrics to watch over the next several quarters are whether components demand keeps rebuilding as the filing anticipates, whether margins hold against the Asian mix shift, and how aggressively the new buyback retires shares while the price sits below sector multiples.

Peer Cohorts (Per Segment, With Filing Citations)

Global Components (reported)

Global ECS (reported)

Methodology Note

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.

Sources

Q1 2026 earnings, May 7 2026 · Q1 2026 earnings, May 7 2026; FY2025 10-K

View the full interactive ARW report on boothcheck